Compare key investment metrics of 신풍제약 and 217270 in real time. Both stocks belong to the 혈장치료 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- By market capitalization, 신풍제약 is larger — ₩428B vs 217270's ₩110B. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 신풍제약's current price of 8,170원 sits at about 6% of its 52-week range (7,700원–15,990원).
- 217270's current price of 2,350원 sits at about 4% of its 52-week range (2,025원–9,800원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 신풍제약 | 217270 |
|---|---|---|
| Price | 8,170원 | 2,350원 |
| PER | 43배 | - |
| PBR | 1.48배 | 0.33배 |
| Market Cap | ₩428B | ₩110B |
| 52-Week High | 15,990원 | 9,800원 |
| 52-Week Low | 7,700원 | 2,025원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 신풍제약 or 217270?
PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share. A lower PER may suggest the stock is undervalued relative to its earnings. Since PER changes with each earnings report, check the real-time comparison table on this page for the latest 신풍제약 and 217270 PER values.
What is the dividend yield difference between 신풍제약 and 217270?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 신풍제약 and 217270 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 신풍제약 and 217270?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.